The European Patent Office (EPO) has published patent application EP4147696A1, titled 'CHIMERIC PROTEIN,' with a publication date of March 11, 2026. The application designates Autolus Limited as the applicant and lists Martin Pule, Ryan Trowbridge, and Edward Hodgkin as inventors. The publication includes International Patent Classification (IPC) codes related to protein engineering and gene manipulation.

This publication represents a new patent filing and does not impose immediate compliance obligations on regulated entities. However, it is relevant for companies operating in the biotechnology and pharmaceutical sectors, particularly those involved in protein-based therapeutics, as it may indicate emerging intellectual property in this field. Legal and R&D departments should monitor the patent's progress and consider its implications for their own research and development activities.